A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Public ClinicalTrials.gov record NCT03670810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The reason for this study is to see how effective and safe the study drug known as lasmiditan is in the acute treatment of 4 migraine attacks with or without aura.
Study identification
- NCT ID
- NCT03670810
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,633 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 23, 2019
- Primary completion
- Jun 11, 2020
- Completion
- Jul 7, 2021
- Last update posted
- Jul 28, 2022
2019 – 2021
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rehabilitation & Neurological Services LLC | Huntsville | Alabama | 35805 | — |
| Barrow Neurological Institute | Phoenix | Arizona | 85013 | — |
| UCSD Altman Clinical & Translational Research Institute (ACTRI) | La Jolla | California | 92121 | — |
| Colorado Neurological Institute | Englewood | Colorado | 80113 | — |
| Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| George Washington University Medical Center | Washington D.C. | District of Columbia | 20037 | — |
| Diamond Headache Clinic | Chicago | Illinois | 60642 | — |
| Ochsner Medical Center - North Shore | Covington | Louisiana | 70433 | — |
| StudyMetrix Research, LLC | City of Saint Peters | Missouri | 63303 | — |
| Nevada Headache Institute | Las Vegas | Nevada | 89113-2237 | — |
| Dent Neurological Institute | Amherst | New York | 14226 | — |
| Island Neuro Associates,PC | Plainview | New York | 11803 | — |
| Montefiore Headache Center | The Bronx | New York | 10461 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007-4209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.
Recently updated Migraine trials
Other public records listing Migraine. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792291: Behavioral Resources and Awareness for Veterans With Episodic Migraine: Impact on Neurological Disability and Quality of Life- Pilot Not yet recruiting
- NCT07764783: Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine Not yet recruiting
- NCT05755945: A Study of Wearable Devices to Predict Migraines Active, not recruiting
- NCT07754266: Headache Ear Auditory Dizziness Sinus (HEADS) Registry Recruiting
- NCT07616128: Study of EVO756 in Adults With Migraine Recruiting
- NCT07645924: A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03670810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2022 · Synced Sep 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03670810 live on ClinicalTrials.gov.